Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, Massachusetts, 02114, United States
Welcome to the 4th GxP Cloud Compliance Summit
The release of the FDA's new CSA guidance offers life science companies the opportunity to fully capitalize on the advantages of cloud computing - from enhanced resource pooling to expense reduction and rapid scalability. But with the implementation of new guidelines and new systems, come new challenges! Vigilance is imperative around testing and validating your cloud to ensure patient privacy, data security, and quality practices, in addition to creating traceable records of every test and result to present to an auditor. With this in mind, if you're wondering how to simplify validating your cloud in line with CSA and in a way that saves you both time and money, don't miss this solutions-focused conference!
The challenges posed by the immune response is one of the biggest obstacles to developing safe, effective, and durable gene therapies. Over the last two decades, drug developers have observed and begun developing solutions to a wide range of immune responses to AAV vectors. The 4th Annual Gene Therapy Immunogenicity Summit is your opportunity to connect with like-minded peers from gene therapy drug developers, along with leading academics, regulators, and key service providers, all making strides with improving risk assessments, monitoring, and mitigating against AAV gene therapy immunogenicity.
Registering for 2023 will grant you access to keynote plenaries from leading gene therapy figures, deep-dive discussions into pressing preclinical and clinical developments, and highly appraised networking opportunities with 150+ of your peers, all to leave you with the actionable tools, insights, and connections you need to enhance your immunogenicity-focused work.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our